Literature DB >> 22761260

Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium.

Shaomin Peng1, Geliang Gan, Veena S Rao, Ron A Adelman, Lawrence J Rizzolo.   

Abstract

PURPOSE: Chronic, subclinical inflammation contributes to the pathogenesis of several ocular diseases, including age-related macular degeneration. Proinflammatory cytokines affect tight junctions in epithelia that lack claudin-19, but in the retinal pigment epithelium claudin-19 predominates. We examined the effects of cytokines on the tight junctions of human fetal RPE (hfRPE).
METHODS: hfRPE was incubated with interleukin 1-beta (IL-1β), interferon-gamma (IFNγ), or tumor necrosis factor-alpha (TNFα), alone or in combination. Permeability and selectivity of the tight junctions were assessed using nonionic tracers and electrophysiology. Claudins, occludin, and ZO-1 were examined using PCR, immunoblotting, and confocal immunofluorescence microscopy.
RESULTS: Only TNFα consistently reduced transepithelial electrical resistance (TER) >80%. A serum-free medium revealed two effects of TNFα: (1) decreased TER was observed only when TNFα was added to the apical side of the monolayer, and (2) expression of TNFα receptors and inhibitors of apoptosis were induced from either side of the monolayer. In untreated cultures, tight junctions were slightly cation selective, and this was affected minimally by TNFα. The results were unexplained by effects on claudin-2, claudin-3, claudin-19, occludin, and ZO-1, but changes in the morphology of the junctions and actin cytoskeleton may have a role.
CONCLUSIONS: Claudin-19-rich tight junctions have low permeability for ionic and nonionic solutes, and are slightly cation-selective. Claudin-19 is not a direct target of TNFα. TNFα may protect RPE from apoptosis, but makes the monolayer leaky when it is presented to the apical side of the monolayer. Unlike other epithelia, IFNγ failed to augment the effect of TNFα on tight junctions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761260      PMCID: PMC3410691          DOI: 10.1167/iovs.11-8311

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  59 in total

1.  Effects of culture conditions on heterogeneity and the apical junctional complex of the ARPE-19 cell line.

Authors:  Yan Luo; Yehong Zhuo; Masayuki Fukuhara; Lawrence J Rizzolo
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

2.  Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue.

Authors:  Arvydas Maminishkis; Shan Chen; Stephen Jalickee; Tina Banzon; Guangpu Shi; Fei E Wang; Todd Ehalt; Jeffrey A Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

3.  Cytokine profiles and inflammatory cells during HSV-1-induced acute retinal necrosis.

Authors:  Mei Zheng; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

4.  Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis.

Authors:  Hiroshi Takase; Yuri Futagami; Tomoko Yoshida; Koju Kamoi; Sunao Sugita; Yasuhisa Imai; Manabu Mochizuki
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

5.  The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.

Authors:  H Oh; H Takagi; C Takagi; K Suzuma; A Otani; K Ishida; M Matsumura; Y Ogura; Y Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-08       Impact factor: 4.799

6.  Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin.

Authors:  A Youakim; M Ahdieh
Journal:  Am J Physiol       Date:  1999-05

7.  Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement.

Authors:  Martin Konrad; Andre Schaller; Dominik Seelow; Amit V Pandey; Siegfried Waldegger; Annegret Lesslauer; Helga Vitzthum; Yoshiro Suzuki; John M Luk; Christian Becker; Karl P Schlingmann; Marcel Schmid; Juan Rodriguez-Soriano; Gema Ariceta; Francisco Cano; Ricardo Enriquez; Harald Juppner; Sevcan A Bakkaloglu; Matthias A Hediger; Sabina Gallati; Stephan C F Neuhauss; Peter Nurnberg; Stefanie Weber
Journal:  Am J Hum Genet       Date:  2006-09-19       Impact factor: 11.025

Review 8.  Occludin: one protein, many forms.

Authors:  Philip M Cummins
Journal:  Mol Cell Biol       Date:  2011-11-14       Impact factor: 4.272

9.  TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury.

Authors:  Rafia S Al-Lamki; Jun Wang; Peter Vandenabeele; J Andrew Bradley; Sathia Thiru; Dianghong Luo; Wang Min; Jordan S Pober; John R Bradley
Journal:  FASEB J       Date:  2005-10       Impact factor: 5.191

10.  Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis.

Authors:  Dianhong Luo; Yan Luo; Yun He; Haifeng Zhang; Rong Zhang; Xianghong Li; Wawrzyniec L Dobrucki; Al J Sinusas; William C Sessa; Wang Min
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

View more
  22 in total

Review 1.  Regulation of paracellular permeability: factors and mechanisms.

Authors:  Yan-Jun Hu; Yi-Dong Wang; Fu-Qing Tan; Wan-Xi Yang
Journal:  Mol Biol Rep       Date:  2013-09-24       Impact factor: 2.316

2.  Interleukin-13 and age-related macular degeneration.

Authors:  Bo Fu; Zhe-Li Liu; Han Zhang; Feng Gu
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

3.  Xuebijing injection treatment inhibits vasopermeability and reduces fluid requirements in a canine burn model.

Authors:  F-B Tang; Y-L Dai; S Hu; L-Q Ma; J-Y Li; H-P Zhang; W-H Zhang; Y-G Li; H-B Wang; H-Y Lin; Q Hu; L Li
Journal:  Eur J Trauma Emerg Surg       Date:  2017-01-09       Impact factor: 3.693

4.  Squamosamide derivative FLZ inhibits TNF-α-induced ICAM-1 expression via down-regulation of the NF-κB signaling pathway in ARPE-19 cells.

Authors:  Ting-Ting Feng; Ze-Yu Liang; Song Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Correlative mRNA and protein expression of middle and inner ear inflammatory cytokines during mouse acute otitis media.

Authors:  Dennis R Trune; Beth Kempton; Frances A Hausman; Barbara E Larrain; Carol J MacArthur
Journal:  Hear Res       Date:  2015-04-25       Impact factor: 3.208

6.  Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology.

Authors:  Elisabeth Obert; Randy Strauss; Carlene Brandon; Christina Grek; Gautam Ghatnekar; Robert Gourdie; Bärbel Rohrer
Journal:  J Mol Med (Berl)       Date:  2017-01-28       Impact factor: 4.599

7.  Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.

Authors:  G Cheng; T He; Y Xing
Journal:  Eye (Lond)       Date:  2016-03-18       Impact factor: 3.775

8.  S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression.

Authors:  Gumeng Cheng; Kailin Tian; Lu Zhang; Ning Yang; Yiqiao Xing; Tao He
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-11       Impact factor: 3.117

9.  TRP Channels Localize to Subdomains of the Apical Plasma Membrane in Human Fetal Retinal Pigment Epithelium.

Authors:  Peter Y Zhao; Geliang Gan; Shaomin Peng; Shao-Bin Wang; Bo Chen; Ron A Adelman; Lawrence J Rizzolo
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-03       Impact factor: 4.799

10.  Engineering a blood-retinal barrier with human embryonic stem cell-derived retinal pigment epithelium: transcriptome and functional analysis.

Authors:  Shaomin Peng; Geliang Gan; Caihong Qiu; Mei Zhong; Hongyan An; Ron A Adelman; Lawrence J Rizzolo
Journal:  Stem Cells Transl Med       Date:  2013-06-03       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.